• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) JUVEDERM VOLUMA WITH LIDOCAINE 1ML; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) JUVEDERM VOLUMA WITH LIDOCAINE 1ML; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number 94151EC
Device Problems Use of Device Problem (1670); Defective Component (2292); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/15/2018
Event Type  malfunction  
Manufacturer Narrative
Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Device labeling: "5.Precautions ¿ failure to comply with the needle attachment instructions could result in needle disengagement and/or product leakage at the luer-lok® and needle hub connection.".
 
Event Description
Healthcare professional reported that a patient was injected in the malar region for ¿volume loss¿ with 0.5 cc of juvéderm® voluma¿ with lidocaine and during the injection ¿product emerged through the place of tie with the needle.¿ there was a ¿defect in the draw of the syringe (luer lock) with the needle.¿ no injuries occurred.It was reported that the syringe was used more than once.The needle from the package was used.
 
Manufacturer Narrative
Lab analysis of the device found 1 empty syringe of 1.0ml received in an opened tray with cap and without needle.No defect observed.Device history record summary: all released batches are compliant with the processing steps described in the master batch and our specifications and especially the sterilization cycle was recorded as compliant.All microbiological, physical and chemical results (endotoxins, bioburden) are recorded in compliance with our specifications and especially the extrusion force value shows our product¿s expected consistency.There were no non conformities with the different elements of the syringes (syringe, plunger, plunger rod, tip cap, finger grip).The release step combined with the absence of any deviation shows that no element could explain these issues.
 
Event Description
Healthcare professional reported that a patient was injected in the malar region for ¿volume loss¿ with 0.5 cc of juvéderm® voluma¿ with lidocaine and during the injection ¿product emerged through the place of tie with the needle.¿ there was a ¿defect in the draw of the syringe (luer lock) with the needle.¿ no injuries occurred.It was reported that the syringe was used more than once.The needle from the package was used.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JUVEDERM VOLUMA WITH LIDOCAINE 1ML
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR  74370
MDR Report Key7640148
MDR Text Key112420579
Report Number3005113652-2018-00822
Device Sequence Number1
Product Code LMH
Combination Product (y/n)N
PMA/PMN Number
P110033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 10/11/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/26/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2019
Device Catalogue Number94151EC
Device Lot NumberVB20A70834
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/01/2018
Date Manufacturer Received10/03/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age25 YR
-
-